Clinical Trial Update: Observational Study to Evaluate Fluid Resolution and Effectiveness of Brolucizumab for nAMD in Portugal

View source ↗

Summary

This Portuguese observational study evaluating fluid resolution and effectiveness of brolucizumab for Neovascular Age-Related Macular Degeneration has been term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• BEOVU (BROLUCIZUMAB)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neovascular Age-related Macular Degeneration (nAMD) | Status: TERMINATED